PVLA
NASDAQ · Biotechnology
Palvella Therapeutics Inc
$175.92
+19.07 (+12.16%)
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Price Target
Analyst Price Target
-70.0% upside
Low Target
$42.56
Average Target
$52.81
High Target
$76.13
Current Price
$175.92
Current
$175.92
$175.92
Target
$52.81
$52.81
$42.56
$52.81 avg
$76.13
Scenario Analysis
Bear Case
$42.56
-75.8%
Low target
Base Case
$52.81
-70.0%
Avg target
Bull Case
$76.13
+-56.7%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$166.73
5.5% from high
52-Week Low
$72.23
+143.6% from low
Target vs 52W High
$52.81
-68.3% vs high
Next Earnings Report
Nov 17, 2026
9d
until earnings
EPS Est: $-1.83
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |